Journal Watch · Frontiers in Immunology · 2026

Intragraft donor-specific antibodies reflect histologic heterogeneity in kidney allografts with concurrent serum DSA.

These findings suggest that gDSA may provide additional tissue-level immunologic context for understanding histologic heterogeneity among kidney transplant recipients with circulating sDSA.

Lee H, Roh EY, Kim TS et al.Frontiers in Immunology3 min readPharma relevance 55/100

DOI: 10.3389/fimmu.2026.1878975PMID: 42416074Study type: clinical study

TL;DR

These findings suggest that gDSA may provide additional tissue-level immunologic context for understanding histologic heterogeneity among kidney transplant recipients with circulating sDSA.

Key findings

  • The MFI sum of gDSA was significantly higher in aABMR, aABMR+TCMR, and C4d-only lesions (corrected <i>P =</i> 0.009, 0.035, and 0.007, respectively).
  • In contrast, the sum of sDSA MFI did not differ significantly across the histologic groups.<h4>Conclusions</h4>In kidney transplant recipients with concurrent sDSA, the presence and intensity of gDSA varied according to biopsy-proven histologic findings, most prominently in aABMR and related lesions.
  • These findings suggest that gDSA may provide additional tissue-level immunologic context for understanding histologic heterogeneity among kidney transplant recipients with circulating sDSA.

Numbers at a glance (from the abstract)

100.0%90.9%83.3%44.4%22.7%14.3%95%OR 34

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

Sixty biopsy eluates from 60 patients were tested using a Luminex single antigen bead assay and analyzed according to biopsy findings.<h4>Results</h4>The prevalence of gDSA differed significantly across histologic diagnoses (overall <i>P =</i> 3.3 × 10<sup>-4</sup>), with higher positivity in C4d-only lesions (100.0%), aABMR (90.9%) and aABMR+TCMR (83.3%), whereas lower frequencies were observed in caABMR (44.4%), no rejection (22.7%), and aTCMR (14.3%). The gDSA positive rate in aABMR was significantly higher than that in the no-rejection group (corrected <i>P =</i> 0.003; OR 34, 95% CI 3.5-334).

Full abstract (original)

Background: <h4>Background</h4>Circulating donor-specific antibodies (sDSA) are clinically important markers of alloimmune risk, but their presence or strength does not always correspond to concurrent antibody-mediated rejection (ABMR) in kidney transplantation. We investigated whether intragraft donor-specific antibodies (gDSA) detected in kidney biopsy eluates are associated with histologic findings in recipients with concurrent sDSA positivity.<h4>Methods</h4>All available frozen kidney biopsies in recipients with concurrent weak to moderate sDSA at Seoul National University Hospital between January 2020 and June 2024 were included.

What they did: Sixty biopsy eluates from 60 patients were tested using a Luminex single antigen bead assay and analyzed according to biopsy findings.<h4>Results</h4>The prevalence of gDSA differed significantly across histologic diagnoses (overall <i>P =</i> 3.3 × 10<sup>-4</sup>), with higher positivity in C4d-only lesions (100.0%), aABMR (90.9%) and aABMR+TCMR (83.3%), whereas lower frequencies were observed in caABMR (44.4%), no rejection (22.7%), and aTCMR (14.3%). The gDSA positive rate in aABMR was significantly higher than that in the no-rejection group (corrected <i>P =</i> 0.003; OR 34, 95% CI 3.5-334).

Results & conclusions: The MFI sum of gDSA was significantly higher in aABMR, aABMR+TCMR, and C4d-only lesions (corrected <i>P =</i> 0.009, 0.035, and 0.007, respectively). In contrast, the sum of sDSA MFI did not differ significantly across the histologic groups.<h4>Conclusions</h4>In kidney transplant recipients with concurrent sDSA, the presence and intensity of gDSA varied according to biopsy-proven histologic findings, most prominently in aABMR and related lesions. These findings suggest that gDSA may provide additional tissue-level immunologic context for understanding histologic heterogeneity among kidney transplant recipients with circulating sDSA.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1878975 · PubMed 42416074.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Frontiers in Immunology study find?

These findings suggest that gDSA may provide additional tissue-level immunologic context for understanding histologic heterogeneity among kidney transplant recipients with circulating sDSA.

What type of study is this?

It is a clinical study, published in Frontiers in Immunology in 2026. Sixty biopsy eluates from 60 patients were tested using a Luminex single antigen bead assay and analyzed according to biopsy findings.<h4>Results</h4>The prevalence of gDSA differed significantly across histologic diagnoses (overall <i>P =</i> 3.3 × 10<sup>-4</sup>), with higher positivity in C4d-only lesions (100.0%), aABMR (90.9%) and aABMR+TCMR (83.3%), whereas lower frequencies were observed in caABMR (44.4%), no rejection (22.7%), and aTCMR (14.3%).

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1878975. PubMed ID: 42416074. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Lee H, Roh EY, Kim TS et al.. Intragraft donor-specific antibodies reflect histologic heterogeneity in kidney allografts with concurrent serum DSA.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1878975.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/intragraft-donor-specific-antibodies-reflect-histologic-heterogeneity-in-878975/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides